XWELL INC (XWEL)
NASDAQHealth CarePersonal Products & ServicesSnapshot 2026-09-04
$0.98+0.58%
Close 2026-09-04 · 1-day change
NASDAQHealth CarePersonal Products & ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · XWEL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 28.3 | 29.2 | 33.9 | 30.1 | 55.9 | 73.7 | 8.4 | 48.5 | 50.1 | 48.8 | 12.0 | 22.7 | 1.4 | 1.1 | 0.1 | 0.7 |
| Total Revenues | 28.3 | 29.2 | 33.9 | 30.1 | 55.9 | 73.7 | 8.4 | 48.5 | 50.1 | 48.8 | 12.0 | 22.7 | 1.4 | 1.1 | 0.1 | 0.7 |
| Cost of Revenues | 18.6 | 21.7 | 25.0 | 26.4 | 43.9 | 41.4 | 12.0 | 37.9 | 8.1 | 39.0 | 6.7 | 0.8 | — | — | 12.5 | 0.2 |
| Gross Profit | 9.7 | 7.5 | 8.9 | 3.7 | 12.0 | 32.3 | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 19.7 | 16.0 | 12.5 | 13.0 | 21.2 | 24.2 | 15.9 | 14.3 | 16.2 | 16.6 | 9.7 | 10.2 | 16.4 | 15.3 | 10.2 | — |
| R&D Expenses | — | — | — | — | — | — | — | — | — | — | — | — | 0.9 | 1.5 | 0.5 | 2.0 |
| Operating Income | (17.3) | (15.7) | (16.7) | (28.2) | (31.2) | 4.1 | (40.1) | (15.9) | (34.7) | (14.7) | (17.7) | (10.3) | (111.2) | (40.8) | (22.4) | (6.4) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | 2.9 | 1.8 | 0.7 | 1.7 | 2.6 | — | — | — | — |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | (1.2) | (1.3) | (1.6) | (1.8) | — | — | — | — |
| Asset Writedown | — | 6.3 | 4.5 | 8.9 | 4.6 | 0.1 | 5.0 | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (22.3) | (16.1) | (16.4) | (28.0) | (32.6) | 2.9 | (92.2) | (20.7) | (35.9) | (16.0) | (19.3) | (12.1) | (109.2) | (41.7) | (18.4) | (7.4) |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | (0.1) | (0.3) | 0.1 | 0.0 | (0.9) | 0.0 | 0.0 | 0.0 | 0.0 |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | (20.5) | (35.6) | (16.1) | — | (11.3) | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | 1.1 | 0.9 | 0.4 | (0.3) | 0.2 | (0.5) | (1.7) | 0.7 | 0.5 | 0.5 | 0.0 | (0.1) | — | — | — | — |
| Net Income | (23.4) | (17.0) | (16.9) | (27.7) | (32.8) | 3.3 | (90.5) | (21.2) | (37.2) | (28.8) | (24.0) | (11.2) | (109.7) | (52.4) | (20.8) | (7.5) |
| Per Share | ||||||||||||||||
| Basic EPS | (2.76) | (5.08) | (3.66) | (6.64) | (7.01) | 0.03 | (2.05) | — | — | (1.29) | (1.58) | (1.09) | (12.24) | (0.63) | (0.53) | — |
| Diluted EPS | (2.76) | (5.08) | (3.66) | (6.64) | (7.01) | 0.03 | (2.05) | — | — | — | (1.58) | (1.09) | (12.36) | (0.63) | (0.61) | — |
| Revenue per Share | 3.33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 8.5 | 5.6 | 4.6 | 4.2 | 4.7 | 104.3 | 44.6 | 1.6 | 1.5 | 1.1 | 15.2 | 10.2 | 9.0 | 83.2 | 39.1 | — |
| Diluted Weighted Avg Shares | 8.5 | 5.6 | 4.6 | 4.2 | 4.7 | 105.1 | 44.6 | 1.6 | 1.5 | 1.1 | 15.2 | 10.2 | 9.0 | 83.3 | 41.7 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (14.8) | (15.8) | (26.1) | (25.7) | 7.3 | (34.9) | (9.7) | (27.3) | (6.7) | (16.4) | (6.8) | (107.2) | (35.6) | (19.9) | (6.4) |
| EBIT | (17.3) | (15.7) | (16.7) | (28.2) | (31.2) | 4.1 | (40.1) | (15.9) | (34.7) | (14.7) | (17.7) | (10.3) | (111.2) | (40.8) | (22.4) | (6.4) |
| Effective Tax Rate | — | — | — | -0.1% | -0.2% | 1.9% | -0.0% | 0.7% | 0.8% | -0.7% | 0.0% | 7.1% | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.